Search & Analyze
Popular Searches
Caplin Point Laboratories Ltd.
Healthcare₹2,464.650.27%
24 Jul, 4:01 PM
CMP₹2,464.65
Mkt Cap₹18.91K Cr
P/E29.48
P/B5.27
ROE21.72%
52W High₹2,700.00
52W Low₹1,502.45
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
29.48
P/B Ratio
5.27
EV/EBITDA
20.86
Price/Sales
8.64
Dividend Yield (%)
0.16
EPS (TTM ₹)
84.36
Book Value (₹)
471.83
ROE (%)
21.72
ROCE (%)
26.22
ROA (%)
18.37
EBITDA Margin (%)
33.39
Net Profit Margin (%)
27.93
Debt/Equity
0.00
Current Ratio
6.97
Interest Coverage
1110.48
Asset Turnover
0.66
Working Capital/Sales
1.06
Core EBITDA Growth (%)
20.21
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 1061.29 | 1269.41 | 1466.73 | 1694.1 | 1937.47 |
| Net Sales | 1061.29 | 1269.41 | 1466.73 | 1694.1 | 1937.47 |
| Total Income | 1089.22 | 1308.3 | 1523.25 | 1761.04 | 2033.9 |
| Total Expenditure | 737.04 | 874.88 | 1026.21 | 1142.66 | 1290.54 |
| Operating Profit | 352.18 | 433.42 | 497.04 | 618.38 | 743.36 |
| Depreciation | 36.97 | 46.9 | 44.99 | 53.44 | 65.96 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 313.62 | 385.82 | 451.35 | 564.43 | 676.78 |
| Tax | 62.19 | 77.37 | 74.36 | 103.01 | 135.69 |
| Profit After Tax (PAT) | 251.43 | 308.45 | 376.99 | 461.42 | 541.09 |
| EPS (₹) | 32.03 | 39.61 | 49.62 | 60.19 | 70.57 |
| Dividend Payout % | 150 | 200 | 225 | 250 | 300 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 89.71 | 89.74 | 89.76 | 89.77 | 89.78 |
| Reserves | 1081.33 | 1378.74 | 1775.35 | 2211.72 | 2741.06 |
| Shareholders Funds | 1185.83 | 1483.93 | 1880.48 | 2315.71 | 2850.49 |
| Total Debt | 17.07 | 0.5 | 3.41 | 0.28 | 0.55 |
| Total Liabilities | 1363.61 | 1730.11 | 2177.4 | 2685.57 | 3205.62 |
| Total Assets | 1363.61 | 1730.11 | 2177.4 | 2685.57 | 3205.62 |
| Book Value / Share | 144.9385 | 183.8918 | 235.9065 | 293.2074 | 362.6658 |
| Assets | 1363.61 | 1730.11 | 2177.4 | 2685.57 | 3205.62 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 268.61 | 336.73 | 271.37 | 318.39 | 432.37 |
| Investing Activities | -29.44 | -376.77 | -217.58 | -320.04 | -334.73 |
| Financing Activities | -23.98 | -40.68 | -28.17 | -38.07 | -38.32 |
| Net Cash Flow | 215.19 | -80.72 | 25.62 | -39.72 | 59.32 |
CAPLIPOINT
₹2,464.65
+0.27%